Keymed Biosciences Inc.

HKEX:2162.HK

43.55 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 27.34127.34113.48613.486163.562163.5620.0320.032505055.13555.135000000
Cost of Revenue 1.8681.86810.93110.9317.5097.5090.0240.0241.2691.2698.68.6000000
Gross Profit 25.47325.4732.5552.555156.054156.0540.0080.00848.73248.73246.53546.535000000
Gross Profit Ratio 0.9320.9320.1890.1890.9540.9540.2380.2380.9750.9750.8440.844000000
Reseach & Development Expenses 165.513165.513173.263173.263124.879124.879171.683171.68382.00482.00483.54883.54895.53195.53143.73243.73219.96919.969
General & Administrative Expenses 44.97444.97447.31747.31741.18641.18641.43241.43225.52425.52432.80932.80913.41813.4186.9896.9893.7863.786
Selling & Marketing Expenses 11.62411.6240021.658027.7360000000-0.054-0.0540.0540.054
SG&A 56.59856.59847.31747.31741.18641.18641.43241.43225.52425.52432.80932.80913.41813.4186.9356.9353.843.84
Other Expenses 000000000000000000
Operating Expenses 222.111222.111220.58223.892148.354148.354168.06168.0655.43755.437177.662177.6621,813.1291,813.129387.428387.42817.58317.583
Operating Income -196.638-196.638-218.025-218.514-10.202-10.202-213.449-213.449-58.797-58.797-71.112-71.112-109.138-109.138-50.682-50.682-23.808-23.808
Operating Income Ratio -7.192-7.192-16.167-16.204-0.062-0.062-6,776.159-6,776.159-1.176-1.176-1.29-1.29000000
Total Other Income Expenses Net 31.37631.37615.85816.34734.27434.27460.38960.38960.05960.059-59.989-59.989-1,706.078-1,706.078-341-3416.0656.065
Income Before Tax -165.262-165.262-202.167-202.16724.07324.073-153.061-153.0611.2621.262-131.101-131.101-1,815.216-1,815.216-391.681-391.681-17.743-17.743
Income Before Tax Ratio -6.044-6.044-14.991-14.9910.1470.147-4,859.063-4,859.0630.0250.025-2.378-2.378000000
Income Tax Expense 3.043.040.7990.7993.7040.5899.3673.724-1.465-1.465-1.696-1.696-0.966-0.966-0.133-0.13300
Net Income -168.373-168.373-203.162-203.16223.48423.484-156.785-156.7852.7272.727-129.405-129.405-1,814.25-1,814.25-391.549-391.549-17.743-17.743
Net Income Ratio -6.158-6.158-15.065-15.0650.1440.144-4,977.286-4,977.2860.0550.055-2.347-2.347000000
EPS -0.64-0.64-0.78-0.780.090.09-0.6-0.60.010.01-0.51-0.51-27.04-27.04-5.84-5.84-0.26-0.26
EPS Diluted -0.64-0.64-0.78-0.780.0880.088-0.6-0.60.010.01-0.51-0.51-27.04-27.04-5.84-5.84-0.26-0.26
EBITDA -177.899-177.899-201.948-201.948-0.953-0.953-206.678-206.678-54.431-54.431-68.392-68.392-105.457-105.457-46.7-46.7-20.843-20.843
EBITDA Ratio -6.507-6.507-14.975-14.975-0.006-0.006-6,561.19-6,561.19-1.089-1.089-1.24-1.24000000